Stay updated on Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. This appears to be a minor internal update with no impact on study details or user interactions.
    Difference
    0.1%
    Check dated 2026-01-14T03:47:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-12-23T20:30:28.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    A new revision number v3.3.2 is shown, replacing the previous v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T22:00:30.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The NIH government operating status notice displayed on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T20:00:27.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Minor formatting tweaks and small content updates on the study details page; the core study information and structure remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:50:53.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Major update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-06T04:24:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.